[1]
2026. PHARMACOBIOCHEMICAL EVALUATION OF RENOPROTECTIVE AGENTS IN CHRONIC KIDNEY DISEASE. Genetics and Molecular Research. (May 2026). DOI:https://doi.org/10.4238/s9gmbg98.